A randomized phase 2 trial of combretatstatin A4 phosphate (CA4P) in combination with paclitaxel and carboplatin to evaluate safety and efficacy in subjects with advanced imageable malignancies

被引：0
|
作者：
Akerley, W. L. [1 ]
Schabel, M. [1 ]
Morrell, G. [1 ]
Horvath, E. [1 ]
Yu, M. [1 ]
Johnsson, B. [1 ]
Arbogast, K. [1 ]
机构：
[1] Univ Utah, Salt Lake City, UT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14060
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer
    Rustin, G. J.
    Shreeves, G.
    Nathan, P. D.
    Gaya, A.
    Ganesan, T. S.
    Wang, D.
    Boxall, J.
    Poupard, L.
    Chaplin, D. J.
    Stratford, M. R. L.
    Balkissoon, J.
    Zweifel, M.
    BRITISH JOURNAL OF CANCER, 2010, 102 (09) : 1355 - 1360
  • [2] A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer
    G J Rustin
    G Shreeves
    P D Nathan
    A Gaya
    T S Ganesan
    D Wang
    J Boxall
    L Poupard
    D J Chaplin
    M R L Stratford
    J Balkissoon
    M Zweifel
    British Journal of Cancer, 2010, 102 : 1355 - 1360
  • [3] Phase I Trial of Combretastatin A4 Phosphate (CA4P) in Combination with Bevacizumab in Patients with Advanced Cancer
    Nathan, Paul
    Zweifel, Martin
    Padhani, Anwar R.
    Koh, Dow-Mu
    Ng, Matthew
    Collins, David J.
    Harris, Adrian
    Carden, Craig
    Smythe, Jon
    Fisher, Nita
    Taylor, N. Jane
    Stirling, J. James
    Lu, Shiao-Ping
    Leach, Martin O.
    Rustin, Gordon J. S.
    Judson, Ian
    CLINICAL CANCER RESEARCH, 2012, 18 (12) : 3428 - 3439
  • [4] A phase 1b trial of combretastatin A-4 phosphate (CA4P) in combination with carboplatin or paclitaxel chemotherapy in patients with advanced cancer
    Rustin, GJS
    Nathan, PD
    Boxall, J
    Saunders, L
    Ganesan, TS
    Shreeves, GE
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 217S - 217S
  • [5] A phase I study of combretastatin A4 phosphate (CA4P) and bevacizumab in subjects with advanced solid tumors
    Nathan, P. D.
    Judson, I.
    Padhani, A.
    Harris, A.
    Carden, C. P.
    Smythe, J.
    Collins, D.
    Leach, M.
    Walicke, P.
    Rustin, G. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] A phase I study of the safety, tolerability and antitumor activity of escalating doses of combretastatin A4 phosphate (CA4P) given in combination with bevacizumab to subjects with advanced solid tumors
    Nathan, Paul
    Judson, Ian
    Padhani, Anwar
    Harris, Adrian
    Sinha, Rajesh
    Jane, Boxall
    Smythe, Jon
    Fisher, Nita
    Taylor, Jane
    Collins, David
    Connors, Hillori
    Gordon, Rustin
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3435S - 3435S
  • [7] Phase 1b trial of combretastatin A4 phosphate (CA4P) in combination with radiotherapy (RT): Initial clinical results
    Ng, QS
    Carnell, D
    Milner, J
    Meer, K
    Saunders, MI
    Hoskin, PJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 221S - 221S
  • [8] A dose escalation study combining combretastatin a 4 phosphate (CA4P) with carboplatin or paclitaxel in patients with advanced cancer.
    Rustin, GJ
    Nathan, PD
    Boxall, J
    Saunders, L
    Ganeson, TS
    Wang, D
    Gaya, A
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8968S - 8968S
  • [9] Phase II study of combretastatin A4 phosphate (CA4P) in patients with advanced anaplastic thyroid carcinoma (ATC).
    Cooney, M. M.
    Savvides, P.
    Agarwala, S.
    Wang, D.
    Flick, S.
    Bergant, S.
    Bhakta, S.
    Lavertu, P.
    Ortiz, J.
    Remick, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 300S - 300S
  • [10] Combretastatin A-4 phosphate (CA4P) carboplatin and paclitaxel in patients with platinum-resistant ovarian cancer: Final phase II trial results
    Zweifel, M.
    Jayson, G.
    Reed, N.
    Osborne, R.
    Hassan, B.
    Shreeves, G.
    Poupard, L.
    Walicke, P. A.
    Balkissoon, J.
    Chaplin, D.
    Rustin, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345